EML4 and lung carcinoma: In addition to TFG-ALK in lung cancer, some ALK fusions have been reported without histopathological evidence: TPM4-ALK in esophageal squamous cell carcinoma [31], [32] and EML4-ALK in colon and breast carcinomas [33].